GENEVA, April 8 -- PHARMA CINQ, LLC (1601 Research BoulevardRockville, Maryland 20850) filed a patent application (PCT/US2025/047859) for "ROD-DERIVED CONE VIABILITY FACTOR FUSION PROTEIN" on Sep 25, 2025. With publication no. WO/2026/072752, the details related to the patent application was published on Apr 02, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): LUO, Tianci (7229 Preservation CourtFulton, Maryland 20759), LIPUT, Daniel (3404 St. Theresa Ct.Olney, Maryland 20832), LIANG, Fong Qi (13504 W. Oak Ct.Mount Airy, Maryland 21771)
Abstract: The present invention relates to a fusion pro...